PM
RMD icon

Parametrica Management’s ResMed RMD Stock Holding History

Parametrica Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,088
Closed -$231K – 221
2020
Q4 		$231K Sell
1,088
-323
-23% -$64.4K 0.14% 143
2020
Q3 		$242K Buy
+1,411
New +$261K 0.46% 66
2018
Q4 		– Sell
-2,064
Closed -$238K – 324
2018
Q3 		$238K Buy
+2,064
New +$226K 0.52% 102
2017
Q3 		– Sell
-3,587
Closed -$279K – 417
2017
Q2 		$279K Buy
3,587
+616
+21% +$44.1K 0.26% 152
2017
Q1 		$214K Buy
+2,971
New +$205K 0.22% 240

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parametrica Management's RMD Position: Q1 2021 in Review

Parametrica Management sold out of ResMed (RMD) in Q1 2021, closing a stake of 1,088 shares — an estimated $231K sold.

Parametrica Management first reported a position in RMD in Q1 2017 and held it in 5 quarters. The position peaked at $279K in Q2 2017. 662 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

  • Parametrica Management reported no remaining ResMed position as of Q1 2021 after selling out during the quarter.
  • Parametrica Management sold 1,088 ResMed shares in Q1 2021, an estimated $231K.
  • Parametrica Management first reported a position in ResMed in Q1 2017 and held it in 5 quarters.
  • Parametrica Management's ResMed position peaked at $279K in Q2 2017.
  • 662 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on Parametrica Management's 13F filing for Q1 2021, filed 14 May 2021.